News

Source: Flickr user David Goehring. Eli Lilly is having another one of those no good, very bad weeks in which its management team probably wished it hadn't rolled out of bed, and shareholders ...
Ladies and gentlemen, let’s talk about Eli Lilly. There’s something curious about the chart below. Nvidia, the poster child of the AI revolution, has seen its share price skyrocket.
Eli Lilly is having another one of those no good, very bad weeks in which its management team probably wished it hadn't rolled out of bed, and shareholders probably wish they hadn't checked their ...
The drug was also the poster child in a group of China-developed medicines that drew Big Pharma interest. Eli Lilly dumps Innovent’s PD-1 cancer drug after FDA rebuff Fierce Pharma ...
Eli Lilly’s quest to get mirikizumab across the finish line has not been easy due to COVID-19 interruptions, the war in Ukraine and continued lockdowns in China. ... “I was at a poster, ...